LYMPHATIC MALFORMATION
Clinical trials for LYMPHATIC MALFORMATION explained in plain language.
Never miss a new study
Get alerted when new LYMPHATIC MALFORMATION trials appear
Sign up with your email to follow new studies for LYMPHATIC MALFORMATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare blood vessel disorders: targeted drugs enter trial
Disease control Recruiting nowThis study tests two targeted drugs for people with vascular malformations (abnormal blood or lymph vessels). It includes 50 participants aged 2 and older. One group with slow-flow malformations and a specific gene mutation receives alpelisib for 48 weeks. Another group with fast…
Matched conditions: LYMPHATIC MALFORMATION
Phase: PHASE2 • Sponsor: Murdoch Childrens Research Institute • Aim: Disease control
Last updated Apr 29, 2026 06:58 UTC
-
Weekly pill may tame painful vascular birthmarks with fewer side effects
Disease control Recruiting nowThis study tests whether taking sirolimus once a week can safely shrink abnormal veins and lymph vessels (called malformations) that cause pain and swelling. About 24 people aged 2 and older will take the drug for 6 months. The goal is to see if weekly dosing works as well as dai…
Matched conditions: LYMPHATIC MALFORMATION
Phase: PHASE2 • Sponsor: Medical University of South Carolina • Aim: Disease control
Last updated Apr 29, 2026 06:56 UTC